UCLA -- A new tuberculosis vaccine engineered by UCLA scientists specifically for HIV-positive people has been shown to be safer and more potent than the current TB vaccine in preclinical studies.
UCLA -- A new tuberculosis vaccine engineered by UCLA scientists specifically for HIV-positive people has been shown to be safer and more potent than the current TB vaccine in preclinical studies.
